The European Medicines Agency has published a template for applications to transfer a veterinary marketing authorisation from one holder to another, in a document dated 29 July 2026. The template, labelled as attachment 1, is intended for use by companies seeking to change the legal ownership of an authorised veterinary medicine within the EU.
The document provides a standardised form to be submitted by both the transferor (current holder) and the transferee (new holder), covering details such as the product name, authorisation number, and contact information for both parties. It also includes sections for the transfer date and signatures. The template aims to streamline the administrative process for such transfers, which are common when companies merge, divest product portfolios, or restructure.
As a procedural template, it does not introduce new regulatory requirements but formalises existing expectations. The publication follows the EMA's ongoing efforts to harmonise and digitise veterinary medicine procedures under the Veterinary Medicines Regulation (EU) 2019/6, which came into full application in January 2022. The template is available on the EMA website for download.
Stakeholders affected include veterinary pharmaceutical companies, particularly those involved in mergers and acquisitions, as well as national competent authorities that process transfer applications. The template reduces the risk of incomplete submissions, potentially speeding up approval times. However, it also imposes a standardised format that may require companies to adjust their internal documentation processes. No impact on consumers or animal health is expected, as the template does not alter safety or efficacy requirements for the medicines themselves.
No prior coverage of this specific template exists in the available record.